← back to search

Abhishek A. Mangaonkar

Mayo Clinic · US
Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, and Chronic Lymphocytic Leukemia Research.
h-index
30
citations
3,481
works
382
NIH funding
primary concept
Medicine
email

Recent publications

Spectrum, prevalence, and clinical correlates of <i>PPM1D</i> mutations in patients with clonal hematopoiesis and clonal cytopenias
Blood Advances 2026cited by 3position: middledoi
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia
Blood 2025cited by 21position: middledoi
Evidence-based risk stratification of myeloid neoplasms harboring <i>TP53</i> mutations
Blood Advances 2025cited by 14position: middledoi
Multihit <scp><i>TP53</i></scp> Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases
American Journal of Hematology 2025cited by 8position: middledoi
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort
Blood Cancer Journal 2025cited by 6position: middledoi
Venous and arterial thrombosis in patients with VEXAS syndrome
Blood 2024cited by 48position: middledoi
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent
American Journal of Hematology 2024cited by 26position: middledoi
Spectrum of clonal hematopoiesis in VEXAS syndrome
Blood 2023cited by 101position: middledoi
Clinical Heterogeneity of the VEXAS Syndrome
Mayo Clinic Proceedings 2021cited by 107position: middledoi
<i>Asxl1</i> loss cooperates with oncogenic <i>Nras</i> in mice to reprogram the immune microenvironment and drive leukemic transformation
Blood 2021cited by 56position: middledoi
A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression
Scientific Reports 2017cited by 37position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Mrinal M. Patnaik · Mayo Clinic2 papers (2021–2025)Kebede H. Begna · Mayo Clinic2 papers (2021–2025)Kaaren K. Reichard · Mayo Clinic2 papers (2021–2025)Matthew J. Koster · Mayo Clinic1 papers (2021–2021)Paola Guglielmelli · Assiut University1 papers (2025–2025) · 1 papers (2021–2021) · 1 papers (2017–2017)Ayalew Tefferi · Mayo Clinic1 papers (2025–2025) · 1 papers (2025–2025)Mithun Vinod Shah · Mayo Clinic1 papers (2025–2025)Animesh Pardanani · Yale Cancer Center1 papers (2025–2025) · 1 papers (2021–2021)Anand Jillella · Augusta University1 papers (2017–2017)Natasha M. Savage · Government Kilpauk Medical College1 papers (2017–2017)James M. Foran · European Society for Blood and Marrow Transplantation1 papers (2025–2025)Tanaz A. Kermani · University of California, Los Angeles1 papers (2021–2021)Attilio Orazi · Providence Hospital1 papers (2025–2025)Ravindra Kolhe · Jackson Laboratory1 papers (2017–2017) · 1 papers (2025–2025)Ashis K. Mondal · Wake Forest University1 papers (2017–2017)